$HOOD may have just had a short term exhausted seller, that wick is substantial.

Freaking NAILED it. Thank you Old Army, one of his old tricks.

Anatomy of a trade post?

Spoony Love said:

---

Anatomy of a trade post?

---

Too early, but I'm in position......will advise.

SPX 4675 was yesterday's low. I'm buying SPY puts if we lose 4675. Adam Mancini has 4675 as an important level as well and that guy is money with his levels.

Triple_Bagger said:

---

SPX 4675 was yesterday's low. I'm buying SPY puts if we lose 4675. Adam Mancini has 4675 as an important level as well and that guy is money with his levels.

---

4675 is also the Woodie's pivot price, and the top of the zone for reversal for Posty's Pivots.

Huge direction of impact down there.

McInnis 03 said:

---

$HOOD may have just had a short term exhausted seller, that wick is substantial.

---

Looks like a similar set up on IRNT happened 10 minutes ago

$ELOX
Into the first gap ($0.85) we go, lets hurry and fill this one and then head to the second at $1.16

McInnis 03 said:

---

Trying AMD long here, DO NOT FOLLOW ME. HIgh risk.

---

May pull rip cord......

BIG vol on the sell, if it gets bought abck up I'll hold a bit longer. Jan dated calls.

McInnis 03 said:

---

BIG vol on the sell, if it gets bought abck up I'll hold a bit longer. Jan dated calls.

---

If it breaks below $140 I will get out.

I will also put the HIGH RISK DO NOT FOLLOW disclaimer.

I got in Dec 23 AMD calls around 142. 138 would be the lowest I would hold and I would get more there. I think it will trade up going into the end of the year.

I think chip manufacturing overall is catching up. The demand will continue to increase, but it will be at a more rational pace.

ETA - I am not necessarily trying to get out today. See AMD's recent history of ripping higher on the open (and in the last 10 minutes of trading).

SNAP ANNOUNCES PARTNERSHIP WITH KIM KARDASHIAN WEST AND KRIS JENNER $SNAP

— Fast Stock Market News (@faststocknewss) December 9, 2021

Hey Baylor, JUPW is growing.

Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading
Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals

Owner of SYNDROS(dronabinol), the only US-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat: Chemotherapy Induced Nausea and Vomiting (CINV) associated in adult patients who have failed to respond adequately to conventional antiemetic treatments; and Anorexia associated with weight loss in adult patients with Acquired Immune Deficiency Syndrome (AIDS)

83,000 square foot manufacturing facility in Texas is FDA registered and licensed by the U.S. DEA to manufacture Schedule I to III controlled substances in a cGMP facility, with a DEA-exemption permit to export globally

Five FDA-registered Investigational New Drugs

Seminal patents in organic and synthetic cannabinoids

Pending license approval to manufacture psychedelic pharmaceuticals

JUPITER, FL and ROUND ROCK, TX, December 9, 2021 Jupiter Wellness, Inc. (Nasdaq: JUPW), announced today it has signed a definitive agreement to acquire Next Frontier Pharmaceuticals, Inc. ("Next Frontier Pharmaceuticals"), through a merger with a subsidiary of Jupiter Wellness. Under the terms of the transaction, Next Frontier Pharmaceuticals' stockholders will receive shares of Jupiter Wellness convertible preferred stock that will be convertible into the common stock of Jupiter Wellness and no cash. The transaction, which has been unanimously approved by the board of directors of both companies, is expected to close in the first quarter of 2022.

Upon the closing of the transaction, the combined company intends to become a leading drug developer and manufacturer of pharmaceutical cannabinoids and psychedelics with a growing portfolio of drug products and intellectual property.

Next Frontier Pharmaceuticals owns the only U.S.-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid, SYNDROS, used in adults to treat: CINV in adult patients who have failed to respond adequately to conventional antiemetic treatments; and Anorexia associated with weight loss in adult patients with AIDS. Next Frontier Pharmaceuticals is also pursuing a 505(b)(2) approval pathway with the FDA for several Investigational New Drugs (INDs) for indications including opioid withdrawal, pain, migraines, and nausea and vomiting associated with chemotherapy. The Company's 83,000 square foot manufacturing facility in Texas is FDA registered and licensed by the U.S. DEA to manufacture Schedule I to III controlled substances in a cGMP facility. The facility currently operates as a contract manufacturer of active pharmaceutical ingredients (APIs). Next Frontier Pharmaceuticals also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids.

"Jupiter Wellness was established with a vision to become a leading pharmaceutical cannabinoid company. Today, with the signing of the merger agreement with Next Frontier Pharmaceuticals, we will have the foundational drug development and formulation team and manufacturing assets to become such a leader. With its industry-leading cannabinoid platform, innovative products, and pipeline, we strongly believe that Next Frontier Pharmaceuticals positions us well for long-term stockholder value creation," said Brian John, Chief Executive Officer of Jupiter Wellness. "We are joining with a world-class team of executives and board members with a strong track record of execution that share a passion for pursuing differentiated therapies based on cannabinoids and psychedelics."

Held with Diamond hands when it fell to 1.20. Hope it can run to $4-6 like I was told ;-)

BaylorSpineGuy said:

---

Held with Diamond hands when it fell to 1.20. Hope it can run to $4-6 like I was told ;-)

---

Same. I added some when it dipped back to the 1.20s this morning.

Not sure it happens or not, but I feel like I've seen this show before where NQ touches the previous day low 3-4 times, never gets broken, and then moon rip occurs.

TBD.

McInnis 03 said:

---

Not sure it happens or not, but I feel like I've seen this show before where NQ touches the previous day low 3-4 times, never gets broken, and then moon rip occurs.

TBD.

---

Nope. There she fails.

Grabbed TSLA 1060C lottos for tomorrow, small.

You think it'll shoot up??

I think 1060 for TSLA is easily attained. All Elon has to do is say something positive. He alone could start a Santa rally.

Talon2DSO said:

---

You think it'll shoot up??

---

I think it will recover some, it's been run down today on descending volume.

I like the risk reward right now (entered at 2.55 area, already to $3).

It's got a long term support line that is around 1034. If it runs to that, it's a double.

Just picked up AVCT shares for $1.70 then sold 2.50 covered calls exp 12/17 for .20 a contract. Easy money even if I called out!

Irish 2.0 said:

---

Ragoo said:

---

I think your lottos need to be puts not calls

---

---

Due to CPI report tomorrow?

Honestly I'm not at my computer right now and TSLA was a 50/50 when I left. I wouldn't personally touch it with anything I couldn't afford to lose with a "**** it" attitude

Which index will get hurt more by a high CPI tomorrow? QQQ or SPY? I assume QQQ.

Irish 2.0 said:

---

Honestly I'm not at my computer right now and TSLA was a 50/50 when I left. I wouldn't personally touch it with anything I couldn't afford to lose with a "**** it" attitude

---

That's how I'm treating this play. I'll be out of it before close today one way or another.

So much for getting cheap CHWY puts. It's tanking before earnings

usually a pullback like this ahead of data/ news is bullish when they release the info. Market loves to do the opposite.

I'm bullish here, but with lunch money size lottos!

AG 2000' said:

---

Grabbed TSLA 1060C lottos for tomorrow, small.

---

Got out of this for an $8 loss, didn't like the L2 action.